CIC
TEVA icon

Cornercap Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History

Cornercap Investment Counsel’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,839
Closed -$597K – 163
2025
Q1 		$597K Sell
38,839
-456
-1% -$8.14K 0.31% 134
2024
Q4 		$866K Sell
39,295
-1,779
-4% -$32.4K 0.28% 96
2024
Q3 		$740K Sell
41,074
-23,440
-36% -$410K 0.22% 139
2024
Q2 		$1.05M Buy
+64,514
New +$994K 0.17% 209
2016
Q4 		– Sell
-125,131
Closed -$5.76M – 402
2016
Q3 		$5.76M Sell
125,131
-7,442
-6% -$388K 1.05% 29
2016
Q2 		$6.66M Sell
132,573
-10,550
-7% -$562K 1.27% 24
2016
Q1 		$7.66M Sell
143,123
-12,225
-8% -$717K 1.44% 18
2015
Q4 		$10.2M Sell
155,348
-284
-0.2% -$17.6K 1.94% 2
2015
Q3 		$8.79M Sell
155,632
-6,745
-4% -$437K 1.74% 6
2015
Q2 		$9.6M Sell
162,377
-3,810
-2% -$235K 1.72% 6
2015
Q1 		$10.4M Sell
166,187
-21,701
-12% -$1.26M 1.82% 2
2014
Q4 		$10.8M Sell
187,888
-4,555
-2% -$254K 1.86% 4
2014
Q3 		$10.3M Buy
192,443
+18,200
+10% +$964K 1.89% 8
2014
Q2 		$9.13M Buy
174,243
+9,242
+6% +$472K 1.65% 20
2014
Q1 		$8.72M Buy
165,001
+5,016
+3% +$232K 1.6% 26
2013
Q4 		$6.41M Buy
+159,985
New +$6.3M 1.2% 45

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Cornercap Investment Counsel's TEVA Position: Q2 2025 in Review

Cornercap Investment Counsel sold out of Teva Pharmaceuticals (TEVA) in Q2 2025, closing a stake of 38,839 shares — an estimated $597K sold.

Cornercap Investment Counsel first reported a position in TEVA in Q4 2013 and held it in 16 quarters. The position peaked at $10.8M in Q4 2014. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • Cornercap Investment Counsel reported no remaining Teva Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Cornercap Investment Counsel sold 38,839 Teva Pharmaceuticals shares in Q2 2025, an estimated $597K.
  • Cornercap Investment Counsel first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 16 quarters.
  • Cornercap Investment Counsel's Teva Pharmaceuticals position peaked at $10.8M in Q4 2014.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2025.

Based on Cornercap Investment Counsel's 13F filing for Q2 2025, filed 6 Aug 2025.